Psoriasis may up risk of melanoma, hematologic cancer

March 28, 2017

(HealthDay)—Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

Shivani P. Reddy, from the University of Illinois at Chicago College of Medicine, and colleagues assessed the risk of melanoma and hematologic cancers in patients with psoriasis.

The researchers found that patients with psoriasis had 1.53 times greater risk of developing a malignancy versus patients without psoriasis (P < 0.01). There were no significant differences in risk among patients receiving different treatments (topicals, phototherapy, systemics, or ). For patients who developed malignancy, survival did not differ among those with or without psoriasis.

"Patients with psoriasis may experience an elevated risk of and hematologic cancers, compared with the ," the authors write. "The risk is not increased by systemic or biologic psoriasis therapies."

One author disclosed financial ties to the pharmaceutical industry.

Explore further: Severe psoriasis predominantly affects men

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Severe psoriasis predominantly affects men

March 24, 2017
The fact that men are overrepresented in psoriasis registers and consume more psoriasis care have long led researchers to believe that the common skin disease disproportionally affects men. A unique study with 5,438 Swedish ...

Psoriasis patients at higher risk for arrhythmia

August 27, 2015
(HealthDay)—Patients with psoriasis are at higher risk of developing arrhythmia, even after controlling for other risk factors, according to a study published in the September issue of the Journal of the American Academy ...

CKD, glomerulonephritis risk higher for those with psoriasis

December 22, 2014
(HealthDay)—Psoriasis is associated with a higher risk of developing chronic kidney disease (CKD) and glomerulonephritis (GN), according to a study published online Dec. 15 in the British Journal of Dermatology.

Fatigue occurs in 50 percent with chronic plaque psoriasis

February 15, 2017
(HealthDay)—About half of patients with chronic plaque psoriasis have fatigue, according to a study published online Feb. 9 in the British Journal of Dermatology.

Gastric bypass associated with reduced risk of psoriasis

December 28, 2016
(HealthDay)—Gastric bypass, but not gastric banding, is associated with reduced risk of psoriasis, progression to severe psoriasis, and psoriatic arthritis, according to a study published online Dec. 21 in JAMA Surgery.

AAD: Herpes zoster incidence up with combo tx for psoriasis

March 23, 2015
(HealthDay)—For patients with psoriasis, combination treatment with biologic medications and methotrexate is associated with increased incidence of herpes zoster (HZ), according to a study published online March 22 in JAMA ...

Recommended for you

Metabolites altered in chronic kidney disease

November 22, 2017
Chronic kidney disease (CKD) affects 1 in 7 people in the United States, according to the U.S. National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). These individuals have a very high risk of cardiovascular ...

Rainfall can indicate that mosquito-borne epidemics will occur weeks later

November 22, 2017
A new study demonstrates that outbreaks of mosquito-borne viruses Zika and Chikungunya generally occur about three weeks after heavy rainfall.Researchers also found that Chikungunya will predominate over Zika when both circulate ...

Alcohol consumption and metabolic factors act together to increase the risk of severe liver disease

November 22, 2017
A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population. The findings, which are published in Hepatology, indicate ...

Gastric acid suppressant lansoprazole may target tuberculosis

November 21, 2017
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...

Improving prediction accuracy of Crohn's disease based on repeated fecal sampling

November 21, 2017
Researchers at the University of California San Diego Center for Microbiome Innovation (CMI) have found that sampling the gut microbiome over time can provide insights that are not available with a single time point. The ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.